• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cimarron Healthcare Capital Announces Acquisition of Ascent Behavioral Health

Share:

February 24, 2020

Cimarron Healthcare Capital (“CHC”), a private equity firm focused on making investments into healthcare companies in the lower middle-market, today announced that it has completed the acquisition of Ascent Behavioral Health (“Ascent” or “the Company”) together in partnership with Company’s management team, Monroe Capital (“Monroe”) and Veronis Suhler Stevenson (“VSS”). Ascent provides wilderness therapy, residential treatment and therapeutic boarding school programs for adolescents with mental health issues such as depression, anxiety and attachment disorder. Financial terms of the private transaction were not disclosed

Founded in 1989, Ascent Behavioral Health operates adolescent behavioral health programs throughout Utah. The Company was built by mission-driven founders on principles committed to clinical quality and superior outcomes based on its experiential therapeutic approach. Ascent takes pride in its expert staff and caregivers, top-quality real estate facilities and continued focus on clinical research.

“Ascent has been improving the lives of adolescents and their families through their comprehensive experiential therapeutic programs for over 30 years,” said James Nadauld, Managing Partner of CHC. “Ascent’s leadership team has decades of behavioral healthcare experience and remains committed to delivering on its impressive history of quality care. We are excited to partner with the team in expanding on Ascent’s continuum of behavioral health programs to serve high-need patients in this growing industry.”

The investment will be used to support the expansion of Ascent’s existing programs and potential acquisitions of complementary programs.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

According to industry data, approximately 44 million adults experience mental illness in the US in a given year, with 50 percent of chronic mental illness developing by age 14 and 75 percent developing by age 24. Mental illness is rising among adolescents at an alarming rate, driven in part by increased drug and alcohol usage, and increased screen time spent on mobile devices and social media. The number of youths with severe depression has increased over 5 percent annually for the last decade; 20 percent of adolescents between the age of 13 – 18 live with a mental health condition, 10 percent have a behavior or conduct disorder, and 8 percent have an anxiety disorder.

“We are thrilled to have the support of partners with a proven track record of supporting growth, and who share our vision for providing unmatched clinical care,” said Steve Nadauld, Chief Executive Officer of Ascent. “CHC and its partners delivered a flexible capital solution that will enable us to continue building a robust, patient-centric platform and pursue the next chapter of our growth, while supporting the uniquely individual treatment needs of our local, national and international clients.”

“Families from around the world have trusted the Ascent companies for decades to help their children lead healthier and more fulfilling lives,” said Clay Andrus, Vice President at CHC. “We are proud to provide resources and support for the team to continue this important work.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • TrustHCS, Visionary RCM, T-System, RevCycle+ Merge to Form New Entity CorroHealthTrustHCS, Visionary RCM, T-System, RevCycle+ Merge to Form New Entity CorroHealth
  • Cerecor To Sell Pediatric Portfolio to AYTU BioScienceCerecor To Sell Pediatric Portfolio to AYTU BioScience
  • Amazon Releases Wearable Health Tracker with App Called Amazon HaloAmazon Releases Wearable Health Tracker with App Called Amazon Halo
  • Progenics Stockholders Approve Merger with LantheusProgenics Stockholders Approve Merger with Lantheus
  • Biotia Raises $2.4M for AI-Powered Precision Infectious Disease Detection & DiagnosisBiotia Raises $2.4M for AI-Powered Precision Infectious Disease Detection & Diagnosis
  • Eloxx Pharmaceuticals Acquires Zikani TherapeuticsEloxx Pharmaceuticals Acquires Zikani Therapeutics
  • Shore Capital-Backed IZI Medical Announces Acquisition of RadioMed Corporation, and its VISICOIL™ product family, from IBA S.A.Shore Capital-Backed IZI Medical Announces Acquisition of RadioMed Corporation, and its VISICOIL™ product family, from IBA S.A.
  • 2020 Insights On the Covid-19 impact on Contract Pharmaceutical Manufacturing Market Competitive Situation and Trends by 2025| Catalent, DPx, Lonza, Piramal Healthcare2020 Insights On the Covid-19 impact on Contract Pharmaceutical Manufacturing Market Competitive Situation and Trends by 2025| Catalent, DPx, Lonza, Piramal Healthcare

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications